Delisting risk
Gelteq
Customizable ingestible gels for partner-branded health and animal-health products.
$0.5277
After-hours close−0.03 (−5.00%)
At close$0.5555(−2.56%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions —Insiders 16.29%
Shares outstanding 9.18M · Float 3.64M · 39.6% free float
Institutions13F
No 13F holders on record.
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Nathan J. Givoni | officer: Chief Executive Officer | 657.1K | 7.16% | Mar 18, 2026 |
| Bradley Glenn Karp | officer: Head of Sales and Marketing | 500.0K | 5.45% | Mar 18, 2026 |
| Simon H. Szewach | director | 338.2K | 3.68% | Mar 18, 2026 |
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.